Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_assertion type Assertion NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_head.
- NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_assertion description "[None of the NAT2 (classified as slow vs. fast acetylator), ESR1 or ESR2 polymorphisms were significantly associated with an altered risk of PD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_provenance.
- NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_assertion evidence source_evidence_literature NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_provenance.
- NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_assertion SIO_000772 20304699 NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_provenance.
- NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_assertion wasDerivedFrom befree-20140225 NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_provenance.
- NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_assertion wasGeneratedBy ECO_0000203 NP586032.RA_FOSSqL7fDUUIcslQA--qloN2cQuzRzjcRFgq13GX-Q130_provenance.